Home > Resource Library >
PharmaLex at DIA Europe 2021 - Roundtable
PharmaLex experts were able to have great conversations and exchange ideas in our network. In this year’s roundtable event some exciting topics were discussed, which might not only be important for pharmaceutical companies. Watch the video to get these insights!
Posted:
WatchLife Science Trends in 2021
#ChatsWithChaudhrey with Trevor Brett, PharmaLex on Life Science Trends in 2021
Posted:
Using Technology-enabled Smart Services - what are the benefits?
At PharmaLex we have the technology, know-how and experience to take these raw ingredients and realize real, immediate and lasting benefits for our clients – we call this SMARTPHLEX.
Posted:
SMARTPHLEX - Technology-enabled Smart Solutions
At PharmaLex we have the technology, know-how and experience to take these raw ingredients and realize real, immediate and lasting benefits for our clients – we call this SMARTPHLEX.
Posted:
SMARTRISK - What is SMARTRISK
SMARTRISK was developed as a response to the EU guidance that was published in 2015 regarding excipient risk assessment for medicinal products to provide a way of performing the risk assessment in a compliant manner, but that was easy for the user.
Posted:
FORBES LEADER’S TALK: The challenges of the biotech market
Sophie Guillaume, General Manager and Patrick Larcier, Senior Director, Drug Development & Vigilance, PharmaLex France, discuss the challenges of the biotech market
Posted:
Who are PharmaLex and what do we do?
As a specialized provider, the services PharmaLex offers are essential to enable companies to maximize their development process and reduce their time to market.
This animation will give you a short overview of who we are, what we do and how we can support your company.
Posted: